Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Q2 vs Q3 (corrected)
View:
Post by RoseHeaven on Nov 29, 2022 11:17pm

Q2 vs Q3 (corrected)

Days
 90D 180D 270D 360D 450D
2Q2022 3Q2022 2Q2022 3Q2022 2Q2022 3Q2022 2Q2022 3Q2022 2Q2022 3Q2022
CR 19 23 16 17 13 15 9 10 5 8
PR 6 6 9 9 7 7 3 5 3 3
TR (CR+PR) 25 29 25 26 20 22 12 15 8 11
NR 13 14 9 12 12 15 14 19 16 18
Pending 7 11 11 16 13 17 19 20 21 25
Evaluable 38 43 34 38 32 37 26 34 24 29
Comment by riverrrow on Nov 30, 2022 9:22am
Not only are the clinical trial results amazing, they continue to get even better.  I'm so confident the market will reflect the true value of TLT (at least 50 cents a share)  that I've put in a big buy order at 25 cents for today.  GLTA.
Theralase Technologies Inc.